<DOC>
	<DOCNO>NCT01400815</DOCNO>
	<brief_summary>A randomized , active control clinical trial total 216 healthy smoker enrol follow approximately 19 week . The trial evaluate efficacy safety use X-22 smoking cessation aid . Healthy smoker plan quit smoking screen eligibility . Subjects randomize 1:1 ratio 1 2 treatment arm : - Group 1 : X-22 Cigarettes ( low nicotine ) - Group 2 : Active Control Cigarettes The randomization stratify gender . Efficacy assess analysis cigarette consumption use self-report diary measurement exhale CO cotinine concentration . Safety assess evaluation adverse event , physical examination , clinical laboratory test , measurement heart rate , blood pressure , body weight study visit .</brief_summary>
	<brief_title>Randomized Trial Evaluate Effectiveness X-22 Smoking Cessation Aid</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>Subjects must meet follow inclusion criterion eligible participation study . 1 . Subjects must consider investigator general good health 18 65 year age , inclusive . 2 . Subjects must history smoking least 10 cigarette per day least 1 year , le 3 month abstinence past year , continuous smoke history least 3 month prior study entry . 3 . Subjects must indicate plan quit smoke within next 3 month . 4 . Subjects must CO measurement ≥ 10 ppm screen baseline ( Visit 1 Visit 2 ) . 5 . Subjects must willing able return schedule followup examination total 5 month . 6 . Female subject must postmenopausal previous 6 month surgically sterile , must negative pregnancy test use one follow acceptable method birth control duration study least 3 month prior screen : abstinence , mean total lack sexual activity , oral contraceptive ( `` pill '' ) , contraceptive injection , intrauterine device , doublebarrier method ( diaphragm condom plus spermicidal cream ) , contraceptive patch , hormonal implant , hormonal vaginal ring , male partner sterilization least 3 month prior screen . 7 . Subjects must sign give copy write Informed Consent form . 8 . Subjects must able read , understand complete questionnaire independently . Subjects meet follow exclusion criterion enrol study . 1 . Subjects household member already enrol trial . 2 . Subjects attempt quit smoking use one FDAapproved smoke cessation product ( eg , NRT include nicotine gum , nicotine lozenge , nicotine patch , nicotine nasal spray , nicotine inhaler ; Zyban [ bupropion ] ; Chantix [ varenicline ] ) longer 1 week past 3 month . 3 . Subjects enrol another structure smoking cessation program ( e.g. , behavioral modification , hypnosis , acupuncture , alternative therapy ) last 30 day . 4 . Subjects another smoking cessation trial past 6 month . 5 . Subjects regularly use ( great per month ) tobaccobased product cigarette ( eg , chew , snuff , snus , shisha , etc. ) . 6 . Subjects history coronary artery disease , myocardial infarction , stroke , chronic obstructive pulmonary disease , significant pulmonary disease . Controlled hypertensive subject mild asthmatic whose disease control asneeded inhaled beta agonist acceptable . 7 . Subjects history cancer within past 60 month basal cell carcinoma . 8 . Subjects history thromboembolic disease take warfin anticoagulant , antiplatelet drug clopidogrel ( Plavix® ) pentoxifylline ( Trental® ) . Low dose aspirin therapy acceptable . 9 . Subjects screen laboratory abnormality consider investigator clinically significant . 10 . Subjects body mass index ( BMI ) &gt; 35 . 11 . Subjects poorly control diabetes insulindependent diabetes . 12 . Subjects know serious pathophysiology topical systemic disorder kind would confound result study . 13 . Subjects screen ECG abnormality consider investigator clinically significant . 14 . Subjects used illegal drug past 3 month . 15 . Subjects positive urine drug screen result . 16 . Subjects pregnant lactating , plan become pregnant course study . 17 . Subjects participate clinical trial investigational drug device time clinical investigation within 30 day prior Screening visit . 18 . Subjects take antidepressant , antipsychotic , clonidine , class drug list RapidCHECK® 12 Panel last 60 day ( see Section 12.1.1 ) . 19 . Subjects systolic blood pressure 140 mmHg and/or diastolic blood pressure 90 mmHg . 20 . Subjects consume average 3 drink alcohol per day . 21 . Subjects consume great average 2 pack cigarette per day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>smoking</keyword>
	<keyword>smoke cessation</keyword>
	<keyword>quit smoking</keyword>
</DOC>